Newsletter | April 3, 2026

04.03.26 -- Zymeworks Shares Its Design Rationale (And Wins) In Early-Phase ADC Trials

FOCUS ON CLINICAL TRIALS

Zymeworks Shares Its Design Rationale (And Wins) In Early-Phase ADC Trials

Zymeworks CMO Sabeen Mekan, MD, explains how scientific gains in ADC therapies have influenced first-in‑human trial design.

Why We Need To Look To The Future Of Clinical Trials

Explore how decentralized trial elements, community-focused site networks, and patient-centric infrastructure can improve recruitment, data quality, equity, and efficiency.

How AI Supports Data Recording And Quality

AI speeds early‑phase development by streamlining data review, enabling structured queries, accelerating PK/PD work, and revealing biomarker patterns — boosting efficiency with expert oversight.

Dispelling 4 Common Clinical Trial Oversight Myths

Many clinical trial oversight problems can be avoided or mitigated by sponsors by understanding root causes and being a proactive collaborator with their partners.

Services That Support Early-Stage Biotech Companies To Secure Funding

Navigate funding challenges for your biotech company with services that combine strategic foresight, operational efficiency, and financial incentives to bring your innovative therapies to market.

SPONSOR

Accelerating TCR-Based Therapies Into & Through the Clinic

The 7th TCR Based Therapies Summit is your pivotal industry-focused meeting uniting global leaders advancing T cell receptor–based cell and biologic therapies. Taking place this May, in Boston, we will delve into the field’s most urgent scientific, translational, and commercial challenges, to support the progression of durable, scalable TCR therapies to the clinic and beyond.

CLINICAL TRIALS SOLUTIONS

When Clinical Trials Drift Off Course, Let Us Help Find Your Path - Biorasi

FOCUS ON SUPPLY CHAIN

The Importance Of Quality In Raw Material Selection

Learn how to select high-quality raw materials for cell-based manufacturing in this exploration of the criticality of raw materials, from preclinical development to commercialization.

SUPPLY CHAIN SOLUTIONS

Flexible Freeze Container To Minimize Product Loss - W.L. Gore & Associates

Connect With Cell & Gene: